The Scleroderma Research Foundation (SRF) is the nation's leading nonprofit investor in medical research aimed at discovering improved therapies and, ultimately, a cure for people living with scleroderma. Founded in 1987 by patient and activist Sharon Monsky, the SRF funds and facilitates the most promising, highest quality research and works to increase awareness of this life-threatening illness. To date, the SRF has invested more than $30,000,000 in groundbreaking science at some of the world's most prestigious research institutions and continues to lead the way in the search for improved therapies and a cure.